Clinical Trial Update: Vedolizumab (Anti-alpha4beta7) in Subjects With HIV Infection Undergoing Analytical Treatment Interruption [Phase 1]

View source ↗

Summary

Phase 1 trial updating vedolizumab for HIV infection under analytical treatment interruption completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV | Phase 1 | Status: COMPLETED | Results posted: 2019-12-16